Oryzon Participates in Three Healthcare and Biotech Events
Oryzon Genomics is participating in three events in the healthcare and biotechnology sectors.
Related stories
Cognizant Q3 Adjusted Earnings and Revenue Rise; Narrows 2026 Guidance
Cognizant reported higher adjusted earnings and revenue for Q3 and narrowed its 2026 guidance.
M impact | EQUITY | Oct 29, 2026, 11:41 AM UTC
LKQ Suspends Specialty Division Review and Sale Process
LKQ said Thursday it has paused a strategic review of its specialty division, including a possible sale.
L impact | EQUITY | Oct 29, 2026, 11:27 AM UTC
Yuexiu Property Acquires Land for Housing Development in Chengdu
Yuexiu Property acquired a plot of land for housing development in Chengdu. The body says it was auctioned on the 29th.
M impact | EQUITY | Oct 29, 2026, 11:26 AM UTC
Slam Accepts Conditional Offtake Offer for 40,000 Wet Tonnes of Ore
Slam accepted Ocean Partners’ conditional offtake offer for 40,000 wet metric tonnes of zinc-lead-copper-silver ore from New Brunswick.
M impact | EQUITY | Oct 29, 2026, 11:26 AM UTC
Panth Infracon Shares Jump Over 10% After Q2 Results
Panth Infracon shares rose over 10% in Thursday trading after the company released results for the quarter ended September 30, 2026, on October 27.
M impact | EQUITY | Oct 29, 2026, 11:26 AM UTC
HUL vs Nestle India shares compared: Which FMCG stock to buy post Q2 results: Who wins on profit, revenue and dividend?
New Delhi, Oct. 29 -- HUL and Nestle India have delivered sharply different profit growth in the September quarter, setting up a fresh battle for investors choosing between two of
M impact | EQUITY | Oct 29, 2026, 11:26 AM UTC